MIB-626

· Metro International Biotech, LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MIB-626, covering 2024-08-27 to 2026-01-21. Get the full timeline:

Most recent: Clinical Trial Update: Effects of MIB-626 With and Without A High-Intensity Multi-Dimensional Exercise Training Program [Phase 2]